- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
ARVO names new president
Todd Margolis, MD, PhD, has been named the new president of the Association for Research in Vision and Ophthalmology.
Rockville, MD-Todd Margolis, MD, PhD, has been named the new president of the Association for Research in Vision and Ophthalmology (ARVO). He is a professor of ophthalmology and director of the Francis I. Practor Foundation at the University of California, San Francisco (UCSF).
"During the coming year," said Dr. Margolis, "I'm looking forward to working with the ARVO staff and board of trustees to bring greater value to the ARVO membership. ARVO is a great organization with an amazing diversity of scientists as members and a unique collegiality. It should be a fun and productive year."
Dr. Margolis received his PhD in neuroscience at UCSF. In addition to being a clinician, he pursues clinical research aimed at understanding the pathogenic mechanisms leading to atypical clinical presentations of herpes simplex virus eye disease.
Dr. Margolis serves on the National Advisory Eye Council of the National Eye Institute and is a member of the American Academy of Ophthalmology, the American Society for Microbiology, and the Society for Neuroscience. He has been an ARVO member since 1984 and an ARVO trustee for immunology and microbiology since 2004.
